FIBROBIOLOGICS INC: CYWC628, FOR UTILIZATION IN A DIABETIC FOOT ULCER (DFU) CLINICAL TRIAL SLATED TO BEGIN IN 2025.

Reuters · 10/18 12:30

Please log in to view news